SynthesisBreast cancer (Tokyo, Japan)2023

Prognosis difference between HER2-low and HER2-zero breast cancer patients: a systematic review and meta-analysis.

Chengxin Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.